Loading...

HEREDITARY MULTIPLE EXOSTOSES GENE PANEL BY NGS, EDTA BLOOD

image not found

NABL Cap Accredited 
The Hereditary Multiple Exostoses Gene Panel by NGS evaluates key genes associated with the development of multiple benign bone growths (exostoses). This advanced test uses an EDTA blood sample to detect mutations that disrupt normal bone growth regulation. Metropolis Healthcare applies high-precision next-generation sequencing to ensure comprehensive and accurate genetic assessment. The findings aid in confirming diagnosis, guiding clinical management, and supporting family risk evaluation 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes:G0205

Frequently Asked Questions (FAQ's):

What does the Hereditary Multiple Exostoses Gene Panel include at Metropolis Healthcare?
It analyzes major genes linked to multiple exostoses using advanced next-generation sequencing for precise mutation detection.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare isolates DNA from EDTA blood and sequences targeted genes with high-quality NGS technology.

Who should consider this test at Metropolis Healthcare?
Individuals with multiple bone growths, skeletal abnormalities, or a family history of hereditary exostoses may benefit from this panel.

What sample does Metropolis Healthcare require for this test?
A simple EDTA blood sample is used to obtain high-quality DNA for genetic analysis.

How soon can I expect results from Metropolis Healthcare?
Reports are typically provided within a standard genetic testing turnaround time following thorough sequencing and interpretation.

Why choose Metropolis Healthcare for this test?
Metropolis Healthcare ensures accurate sequencing, comprehensive gene coverage, and clinically meaningful result interpretation.

Does Metropolis Healthcare offer guidance after the test?
Yes, detailed insights accompany the report to help clinicians plan monitoring and management strategies.

Is this test suitable for children at Metropolis Healthcare?

Yes, the panel is appropriate for pediatric and adult patients suspected of having hereditary multiple exostoses. 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab